Desi Viagra avatars among top 10 new brands
new delhi: even though analysts wrote them off, the desi avatars of popular global brand for male erectile dysfunction viagra, have emerged among the top 10 brands launched in 2001. ‘penegra’ by zydus cadila took the top slot, emerging as one of the most sucessful brands launched in 2001 as per org-marg sales estimates. close to follow penegra was ranbaxy laboratories’ ‘caverta’, which grabbed the number four position. cipla’s silagra secured number nine position followed by edegra of sun pharma at number 10 and androz of torrent at number 11 among the new brands launched during january to november this year. among other brands, anti-coagulant cbopigrell by us vitamins and detlatt by torrent took the number two and number three slots, respectively. according to industry sources, domestic versions of viagra managed to garner sales to the tune of about rs 35 crore as against the initial estimates of rs 45 crore. when contacted, ranbaxy’s regional director (india) s.d. kaul said that sildenafil as a molecule had lived up to industry expectations despite most of the brands being described as ‘dead’ by analysts. kaul said that though the sales figures were much away from the industry estimates, it was not that the molecule did not have a market in the country. he hoped the sales to grow by almost 50 per cent in 2002. stating that while drug control authorities had managed to keep off the hype generated by the molecule worldwide, by allowing the drug to be prescribed by a urologist, diabetologist or an endocrinologist, he said that they should consider industry demand of permitting general practioners to prescribe. “usually patients in such a situation tend to approach their family doctor, usually a general practioner in such a situation,” he said, adding going to a urologist or created some kind of psychological hindrance. kaul said that industry had already written to the drug controller about this and hoped that the authorities would take a more pragmatic view on this since the drug has been there for a year now.
Visual Stories
Trending Stories
- ‘Int’l travellers don’t need to furnish any additional info to airlines’
- Rs 50,000 crore forex saved by blending ethanol with petrol: PM
- India to start supplying petrol with 20% ethanol from April 2023
- RBI issues strict norms for digital lending to curb malpractice
- ‘India could emerge as Asia’s strongest economy in 2022-23’
- Here’s how to turn your idea into a business
- Amrita Hospital, Faridabad set to serve humanity
- Asian Paints lauds PV Sindhu for her first CWG gold
- Domestic fare band to be discontinued from Aug 31
- US inflation slips from 40-year peak but remains high at 8.5%
- ‘Good beginning’: Opposition sees Nitish Kumar move as sign of taking fight to BJP
- Live: ‘Nitish wanted to be VP, got angry when BJP refused’
- In Bihar, BJP is a loser today, but Nitish risks the biggest fall
- Not scared of ED and CBI, asserts JD(U) after dumping BJP
- ‘China-Taiwan battle’: War game in US forecasts grim results
- Fare caps on domestic flights to be discontinued from August 31
- Sorry, I won’t fly the Tiranga on Aug 15. This is why
- Justice UU Lalit appointed 49th Chief Justice of India
- Black magic won’t help win trust of people: PM’s dig at Cong
- Watch movie review: Raksha Bandhan
FOLLOW US ON
Other Times Group News Sites
Popular Categories
Hot on the Web
Top Trends
Trending Topics
Living and entertainment
Services
Copyright © 2022 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service
